2015
DOI: 10.1016/j.rcl.2014.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Tissue Characterization of the Myocardium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 67 publications
0
15
0
3
Order By: Relevance
“…CMR with late gadolinium enhancement, in particular, shows wide variation in quantifying focal fibrosis and cannot detect diffuse fibrosis [31, 32]. Other CMR approaches, such as T1 mapping and extracellular volume mapping, are affected by specific CMR techniques and magnetic field strength; they lack reference ranges, and there is a significant overlap of T1 mapping values of healthy and disease states [31, 32]. …”
Section: Myocardial Viability and Fibrosismentioning
confidence: 99%
“…CMR with late gadolinium enhancement, in particular, shows wide variation in quantifying focal fibrosis and cannot detect diffuse fibrosis [31, 32]. Other CMR approaches, such as T1 mapping and extracellular volume mapping, are affected by specific CMR techniques and magnetic field strength; they lack reference ranges, and there is a significant overlap of T1 mapping values of healthy and disease states [31, 32]. …”
Section: Myocardial Viability and Fibrosismentioning
confidence: 99%
“…Med CT kan arr og annen fibrose påvises svaert nøyaktig, men av strålingshygieniske hensyn utføres det sjelden (19). Fibrosevurdering ved hjerte-CT har vist godt samsvar med hjerte-MR-metoder og histologi (17). Metoden vurderes ved kontraindikasjoner mot MR (17) og ved andre indikasjoner for hjerte-CT (27).…”
Section: Ct-undersøkelse Av Hjertetunclassified
“…Myokardfibrose er assosiert med økt myokardstivhet, kardiomyocyttdød, arytmier, plutselig hjertedød og ugunstig prognose (2, 3, 17, 18, 23, 28), og er sentral i remodelleringsprosessen som leder til hjertesvikt (10,17,26). Kransåresykdom, aortastenose og hypertensjon utgjør de hyppigste årsakene til myokardfibrose (13).…”
Section: Myokardfibrose Ved Ulike Sykdomstilstanderunclassified
“…A GLS ≤−11.6% showed a sensitivity of 65% and a specificity of 75% to predict significant FMF (LGE > 10%) [43]. The majority of studies dealing with this issue have focused on DMF [15, 19, 24, 46, 47]. Of the conventional echocardiography-derived parameters, DMF seems to show a significant, though weak, correlation only with LV mass and the LV mass index [23, 24].…”
Section: Relationship Between Myocardial Fibrosis and LV Systolic Funmentioning
confidence: 99%
“…Other limitations need also mentioned. First of all, CMR-derived assessment of FMF using LGE has a wide interobserver variability, depends on the technical setting of the scanner, and does not allow detection of DMF [47]. The CMR-T1-derived T1 relaxation time and ECV are dependent on a specific CMR-T1 sequence, magnetic field strength, and homogeneity.…”
Section: Limitationsmentioning
confidence: 99%